Circulating white blood cell traits and colorectal cancer risk: A Mendelian randomisation study

Author:

Constantinescu Andrei‐Emil123ORCID,Bull Caroline J.123ORCID,Jones Nicholas4,Mitchell Ruth12,Burrows Kimberley12,Dimou Niki5,Bézieau Stéphane6,Brenner Hermann789,Buchanan Daniel D.101112ORCID,D'Amato Mauro131415,Jenkins Mark A.16,Moreno Victor17181920ORCID,Pai Rish K.21,Um Caroline Y.22,White Emily2324,Murphy Neil5ORCID,Gunter Marc5,Timpson Nicholas J.12,Huyghe Jeroen R.24,Vincent Emma E.123

Affiliation:

1. MRC Integrative Epidemiology Unit University of Bristol Bristol UK

2. Bristol Medical School, Population Health Sciences University of Bristol Bristol UK

3. School of Translational Health Sciences, Bristol Medical School University of Bristol Bristol UK

4. Institute of Life Science Swansea University Medical School Swansea UK

5. Nutrition and Metabolism Branch, International Agency for Research on Cancer World Health Organization Lyon France

6. Service de Génétique Médicale Centre Hospitalier Universitaire (CHU) Nantes Nantes France

7. Division of Clinical Epidemiology and Aging Research German Cancer Research Center (DKFZ) Heidelberg Germany

8. Division of Preventive Oncology German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT) Heidelberg Germany

9. German Cancer Consortium (DKTK) German Cancer Research Center (DKFZ) Heidelberg Germany

10. Colorectal Oncogenomics Group, Department of Clinical Pathology The University of Melbourne Parkville Victoria Australia

11. University of Melbourne Centre for Cancer Research Victorian Comprehensive Cancer Centre Parkville Victoria Australia

12. Genetic Medicine and Family Cancer Clinic The Royal Melbourne Hospital Parkville Victoria Australia

13. Department of Medicine and Surgery LUM University Casamassima Italy

14. Gastrointestinal Genetics Lab CIC bioGUNE – BRTA Derio Spain

15. Ikerbasque, Basque Foundation for Science Bilbao Spain

16. Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health The University of Melbourne Melbourne Victoria Australia

17. Oncology Data Analytics Program Catalan Institute of Oncology‐IDIBELL, L'Hospitalet de Llobregat Barcelona Spain

18. CIBER Epidemiología y Salud Pública (CIBERESP) Madrid Spain

19. Department of Clinical Sciences, Faculty of Medicine University of Barcelona Barcelona Spain

20. ONCOBEL Program, Bellvitge Biomedical Research Institute (IDIBELL) L'Hospitalet de Llobregat Barcelona Spain

21. Department of Laboratory Medicine and Pathology Mayo Clinic Arizona Scottsdale Arizona USA

22. Department of Population Science American Cancer Society Atlanta Georgia USA

23. Department of Epidemiology University of Washington School of Public Health Seattle Washington USA

24. Public Health Sciences Division Fred Hutchinson Cancer Center Seattle Washington USA

Abstract

AbstractObservational studies have suggested a protective role for eosinophils in colorectal cancer (CRC) development and implicated neutrophils, but the causal relationships remain unclear. Here, we aimed to estimate the causal effect of circulating white blood cell (WBC) counts (N = ~550 000) for basophils, eosinophils, monocytes, lymphocytes and neutrophils on CRC risk (N = 52 775 cases and 45 940 controls) using Mendelian randomisation (MR). For comparison, we also examined this relationship using individual‐level data from UK Biobank (4043 incident CRC cases and 332 773 controls) in a longitudinal cohort analysis. The inverse‐variance weighted (IVW) MR analysis suggested a protective effect of increased basophil count and eosinophil count on CRC risk [OR per 1‐SD increase: 0.88, 95% CI: 0.78‐0.99, P = .04; OR: 0.93, 95% CI: 0.88‐0.98, P = .01]. The protective effect of eosinophils remained [OR per 1‐SD increase: 0.88, 95% CI: 0.80‐0.97, P = .01] following adjustments for all other WBC subtypes, to account for genetic correlation between the traits, using multivariable MR. A protective effect of increased lymphocyte count on CRC risk was also found [OR: 0.84, 95% CI: 0.76‐0.93, P = 6.70e‐4] following adjustment. Consistent with MR results, a protective effect for eosinophils in the cohort analysis in the fully adjusted model [RR per 1‐SD increase: 0.96, 95% CI: 0.93‐0.99, P = .02] and following adjustment for the other WBC subtypes [RR: 0.96, 95% CI: 0.93‐0.99, P = .001] was observed. Our study implicates peripheral blood immune cells, in particular eosinophils and lymphocytes, in CRC development, highlighting a need for mechanistic studies to interrogate these relationships.

Funder

Cancer Research UK

Diabetes UK

Medical Research Council

National Cancer Institute

NIHR Bristol Biomedical Research Centre

Wellcome Trust

World Cancer Research Fund International

Publisher

Wiley

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3